COST-EFFECTIVENESS ANALYSIS OF FORMOTEROL FOR ASTHMA TREATMENT IN RUSSIAN FEDERATION

被引:0
|
作者
Kulikov, A. [1 ]
Makarova, E. [1 ]
机构
[1] IM Sechenov First Moscow State Med Univ, Moscow, Russia
关键词
D O I
10.1016/j.jval.2016.03.456
中图分类号
F [经济];
学科分类号
02 ;
摘要
PRS35
引用
收藏
页码:A115 / A116
页数:2
相关论文
共 50 条
  • [31] A cost-effectiveness analysis of reslizumab in the treatment of poorly controlled eosinophilic asthma
    Lam, Jenny
    Hay, Joel W.
    Salcedo, Jonathan
    Kenyon, Nicholas J.
    JOURNAL OF ASTHMA, 2019, 56 (08) : 872 - 881
  • [32] THE COST-EFFECTIVENESS OF QUETIAPINE, ARIPIPRAZOLE OR OLANZAPINE IN PATIENTS WITH BIPOLAR DEPRESSION IN THE RUSSIAN FEDERATION
    Kulikov, A.
    Komarov, I
    VALUE IN HEALTH, 2013, 16 (03) : A62 - A62
  • [33] COST-EFFECTIVENESS ANALYSIS OF DACLATASVIR WITH ASUNAPREVIR VS PARITAPREVIR/RITONAVIR/OMBITASVIR WITH DASABUVIR IN TREATMENT OF CHRONIC HEPATITIS C IN THE RUSSIAN FEDERATION
    Yagudina, R.
    Kulikov, A.
    Babiy, V. V.
    VALUE IN HEALTH, 2016, 19 (07) : A415 - A416
  • [34] Cost-effectiveness analysis of budesonide/formoterol maintenance and reliever therapy versus fixed combination treatments for asthma in Finland
    Tamminen, Klaus
    Laine, Juha
    Soini, Erkki
    Martikainen, Janne
    Kankaanranta, Hannu
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (12) : 3453 - 3461
  • [35] COST-UTILITY ANALYSIS OF TWO BUDESONIDE INHALERS FOR TREATMENT OF ASTHMA IN CHILDREN IN RUSSIAN FEDERATION
    Makarova, E.
    Yagudina, R.
    Kulikov, A.
    VALUE IN HEALTH, 2017, 20 (09) : A646 - A647
  • [36] Cost-effectiveness of current and optimal treatment for adult asthma
    Simonella, L
    Marks, G
    Sanderson, K
    Andrews, G
    INTERNAL MEDICINE JOURNAL, 2006, 36 (04) : 244 - 250
  • [37] COST-EFFECTIVENESS OF A STRUCTURED TREATMENT AND TEACHING PROGRAM ON ASTHMA
    TRAUTNER, C
    RICHTER, B
    BERGER, M
    EUROPEAN RESPIRATORY JOURNAL, 1993, 6 (10) : 1485 - 1491
  • [38] Cost-effectiveness of budesonide-formoterol vs inhaled epinephrine in US adults with mild asthma
    Ho, Joseph Khoa
    Shaker, Marcus
    Greenhawt, Matthew
    Sadatsafavi, Mohsen
    Abrams, Elissa M.
    Oppenheimer, John
    Mosnaim, Giselle S.
    Lee, Tae Yoon
    Johnson, Kate M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 132 (02) : 229 - 239.e3
  • [39] COST-EFFECTIVENESS ANALYSIS OF DUPILUMAB FOR THE TREATMENT OF TYPE 2 SEVERE ASTHMA IN ITALY
    Pedone, M. P.
    Fanelli, F.
    Serra, A.
    Bitonti, R.
    Furneri, G.
    VALUE IN HEALTH, 2020, 23 : S722 - S722
  • [40] COST-EFFECTIVENESS ANALYSIS OF OMALIZUMAB IN THE TREATMENT OF UNCONTROLLED SEVERE ALLERGIC ASTHMA IN CHINA
    Zhu, S.
    Xiao, D.
    Wang, L.
    Xuan, J.
    VALUE IN HEALTH, 2019, 22 : S49 - S49